These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30475536)

  • 1. [EPIDEMIOLOGICAL FEATURES OF BREAST CANCER IN THE REPUBLIC OF UZBEKISTAN].
    Miryusupova GF; Khakimov GA; Shayusupov NR
    Vopr Onkol; 2016; 62(4):495-8. PubMed ID: 30475536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.
    Park SJ; Lee MH; Kong SY; Song MK; Joo J; Kwon Y; Lee EG; Han JH; Sim SH; Jung SY; Lee S; Lee KS; Park IH; Lee ES
    Breast Cancer Res Treat; 2018 Jul; 170(1):69-76. PubMed ID: 29516374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes].
    Stöger H
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2096. PubMed ID: 24085364
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential prognostic value of clinical characteristics, hormone status and major depressive disorder in breast cancer.
    Hui L; Huang T; Lian J; Zhou F; Gao C; Lin Y; Tu H; Nan K; Li Z; Wei Y
    Future Oncol; 2017 Jul; 13(17):1493-1503. PubMed ID: 28589742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? No].
    Gampenrieder SP
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2097. PubMed ID: 24085365
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
    Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G
    Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current state of breast cancer classification.
    Viale G
    Ann Oncol; 2012 Sep; 23 Suppl 10():x207-10. PubMed ID: 22987963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor characteristics and metabolic quantification in carcinoma breast: An institutional experience.
    Dubey IP; Jain A; Chauhan MS; Kumar R; Agarwal S; Kishore B; Vishnoi MG; Paliwal D; John AR; Kumar N; Sharma A; Pandit AG
    Indian J Cancer; 2017; 54(1):333-339. PubMed ID: 29199717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer.
    Tong D; Czerwenka K; Heinze G; Ryffel M; Schuster E; Witt A; Leodolter S; Zeillinger R
    Clin Cancer Res; 2006 Apr; 12(8):2442-8. PubMed ID: 16638850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
    Tas F
    Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.
    Lin CS; Chang SC; Ou LH; Chen CM; Hsieh SS; Chung YP; King KL; Lin SL; Wei YH
    Oncol Rep; 2015 Jun; 33(6):2924-34. PubMed ID: 25845386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods.
    Ambrogi F; Biganzoli E; Querzoli P; Ferretti S; Boracchi P; Alberti S; Marubini E; Nenci I
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):781-90. PubMed ID: 16467089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between HER2 Proto-oncogene Status and Prognostic Factors of Breast Cancer in the West of Iran.
    Amirifard N; Sadeghi E; Payandeh M; Mohebbi H; Sadeghi M; Choubsaz M
    Asian Pac J Cancer Prev; 2016; 17(1):295-8. PubMed ID: 26838227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer in Lean Postmenopausal Women Might Have Specific Pathological Features.
    Uomori T; Horimoto Y; Arakawa A; Iijima K; Saito M
    In Vivo; 2019; 33(2):483-487. PubMed ID: 30804130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centromere 17 copy number alteration: negative prognostic factor in invasive breast cancer?
    Petroni S; Addati T; Mattioli E; Caponio MA; Quero C; Rubini V; Giotta F; Simone G
    Arch Pathol Lab Med; 2012 Sep; 136(9):993-1000. PubMed ID: 22938586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers.
    Shi YJ; Tsang JY; Ni YB; Tse GM
    Oncologist; 2017 Apr; 22(4):487-490. PubMed ID: 28341760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
    Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
    BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.